Skip to main content
TipRanks
Go Ultimate75% OFF

Tarsus Pharmaceuticals (TARS) Drug Pipeline

298 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Tp-05 Low Dose, Tp-05 High DoseLyme DiseasePhase IIRecruitingA Study to Evaluate Safety and Efficacy of TP-05 in Healthy Participants With Tick ExposureMar 30, 2026―
Vehicle Control, Lotilaner Ophthalmic Solution, 0.25%Demodex BlepharitisPhase IVCompletedImpact of XDEMVY® on Demodex Blepharitis in Soft Contact Lens WearersDec 13, 2023―
Tp-03, Tp-03 VehicleBlepharitis, Meibomian Gland Dysfunction, Demodex InfestationPhase IICompletedPilot Study Comparing the Safety and Efficacy of Two Dosing Regimens of TP-03 for the Treatment of MGDJun 27, 2022―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Tarsus Pharmaceuticals, Inc. (TARS) have in its pipeline
Tarsus Pharmaceuticals TARS is currently developing the following drugs: Tp-05 Low Dose, Tp-05 High Dose, Vehicle Control, Lotilaner Ophthalmic Solution, 0.25%, Tp-03, Tp-03 Vehicle. These drug candidates are in various stages of clinical development as the company works toward FDA approval.